BidaskClub upgraded shares of Balchem (NASDAQ:BCPC) from a buy rating to a strong-buy rating in a research report report published on Wednesday.
Shares of NASDAQ:BCPC opened at $86.62 on Wednesday. Balchem has a 52 week low of $70.23 and a 52 week high of $88.47. The company has a current ratio of 1.84, a quick ratio of 1.28 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $2,766.35, a price-to-earnings ratio of 34.00 and a beta of 0.94.
Balchem (NASDAQ:BCPC) last announced its quarterly earnings data on Tuesday, February 27th. The basic materials company reported $0.68 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.06. Balchem had a net margin of 15.14% and a return on equity of 14.16%. The company had revenue of $159.26 million for the quarter.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.